SignPath Pharma, Inc. — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2015)

-$1.6M

Total Assets (FY2015)

$697.9K

Total Equity (FY2015)

$388.1K

Cash Flows from Operating Activities (FY2015)

-$1.5M

Source: SignPath Pharma, Inc. 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.